Winway Health Desk
FDA Grants Accelerated Approval to Filspari (sparsentan) for the Reduction of...
FDA Grants Accelerated Approval to Filspari (sparsentan) for the Reduction of Proteinuria in IgA NephropathyFirst single molecule Dual Endothelin Angiotensin Receptor Antagonist (DEARA) approved...
FDA Approves Pfizer’s Supplemental New Drug Application for Cibinqo (abrocitinib) to...
Label expansion for Cibinqo provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
NEW YORK--(BUSINESS WIRE) February 10, 2023...
Teva Announces FDA Approval of Austedo XR (deutetrabenazine) Extended-Release Tablets, a...
New once-daily Austedo XR regimen now approved in 6, 12, and 24 mg tablet strengths
Austedo is the only vesicular monoamine transporter 2 (VMAT2) inhibitor...
FDA Approves Lamzede (velmanase alfa-tycv) for the Treatment of Alpha-Mannosidosis
First and only enzyme replacement therapy for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients
Ultra-rare progressive disease presents...
US FDA Grants Regular Approval for Jemperli for the Treatment of...
Conversion from accelerated to regular (full) approval based on long-term outcomes from the GARNET phase I trial, which demonstrated an overall response rate of...
Tezspire Approved for Self-Administration in the U.S. With a New Pre-filled...
THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved Tezspire®...
Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public...
Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked...
What Will Value-Based Drug Pricing Look Like By 2030? Experts Share...
Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit...
Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy
Geographic atrophy, an eye disorder that starts as a loss of central vision and progressively worsens to total blindness, now has its first treatment....
PBMs Come Under Fire During Senate Hearing
Pharmacy Benefit Managers (PBMs) took a hit from lawmakers during a Thursday hearing held by the Senate Commerce Committee, with some questioning why the...
